
Organizing Pneumonia in Hospitalized COVID-19 Patients: Risk Factors and Long-term Outcomes
Some patients develop post-COVID organizing pneumonia (OP), which is responsiveto treatment with corticosteroids.
Some patients develop post-COVID organizing pneumonia (OP), which is responsiveto treatment with corticosteroids.
1 year after an acute COVID-19 episode, patients with either lung sequelae or long COVID show a stronger SARS-CoV-2-specific T-cell response than fully recovered individuals, suggesting persistent cell stimulation by residual viral reservoirs